Company Filing History:
Years Active: 1992-1994
Title: Richard J Sharpe: Innovator in Cancer Treatment
Introduction
Richard J Sharpe is a notable inventor based in Newton, MA (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a total of 2 patents, Sharpe's work focuses on novel therapeutic approaches to combat metastatic cancer and angiogenic diseases.
Latest Patents
Sharpe's latest patents include a groundbreaking method for the systemic treatment of metastatic cancer using platelet factor 4. This invention involves the systemic administration of recombinant Platelet Factor Four (rPF4) to inhibit tumor growth in mammals suffering from metastatic cancer. Additionally, he has developed novel methods and compositions for the treatment of angiogenic diseases. This patent pertains to the use of recombinant PF4 (rPF4) and its analogs to inhibit angiogenesis, demonstrating utility in treating various angiogenic diseases and inhibiting endothelial cell proliferation.
Career Highlights
Richard J Sharpe is currently associated with Repligen Corporation, where he continues to advance his research in cancer therapies. His work has garnered attention for its potential to improve treatment outcomes for patients with challenging medical conditions.
Collaborations
Sharpe collaborates with various professionals in the field, including his coworker Theodore E Maione, to further enhance the impact of his inventions.
Conclusion
Richard J Sharpe's innovative contributions to cancer treatment exemplify the importance of research and development in the medical field. His patents reflect a commitment to finding effective solutions for complex health issues.